Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Health Law Apr 2018 Plastic Surgery Overseas: How Much Should a Physician Risk in the Pursuit of Higher-Quality Continuity of Care? Scott Schweikart, JD, MBE Medical tourism creates an ethical dilemma for domestic physicians who wish to provide continuity of care but avoid liability in a malpractice suit. AMA J Ethics. 2018;20(4):357-365. doi: 10.1001/journalofethics.2018.20.4.hlaw1-1804. Policy Forum Jun 2018 Defining Adequate Quality and Safety Metrics for Burn Care Laura S. Johnson, MD and Jeffrey W. Shupp, MD Burn care physicians must walk a fine line between providing individualized care and applying population-based quality metrics. AMA J Ethics. 2018;20(6):567-574. doi: 10.1001/journalofethics.2018.20.6.pfor1-1806. Health Law Mar 2009 Difficult Patient-Physician Relationships and the Risk of Medical Malpractice Litigation Kristin E. Schleiter, JD Virtual Mentor. 2009;11(3):242-246. doi: 10.1001/virtualmentor.2009.11.3.hlaw1-0903. Policy Forum Oct 2004 The Universal Protocol Dennis S. O'Leary, MD Virtual Mentor. 2004;6(10):456-458. doi: 10.1001/virtualmentor.2004.6.10.pfor1-0410. Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410. Medical Education Oct 2004 Acknowledging the Limits of Individual Competence Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):446-448. doi: 10.1001/virtualmentor.2004.6.10.medu1-0410. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Viewpoint Feb 2016 Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters. AMA J Ethics. 2016;18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602. Policy Forum Feb 2016 Regulations’ Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? Joel T. Adler, MD, MPH and David A. Axelrod, MD, MBA Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit. AMA J Ethics. 2016;18(2):133-142. doi: 10.1001/journalofethics.2017.18.2.pfor1-1602. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Health Law Apr 2018 Plastic Surgery Overseas: How Much Should a Physician Risk in the Pursuit of Higher-Quality Continuity of Care? Scott Schweikart, JD, MBE Medical tourism creates an ethical dilemma for domestic physicians who wish to provide continuity of care but avoid liability in a malpractice suit. AMA J Ethics. 2018;20(4):357-365. doi: 10.1001/journalofethics.2018.20.4.hlaw1-1804.
Policy Forum Jun 2018 Defining Adequate Quality and Safety Metrics for Burn Care Laura S. Johnson, MD and Jeffrey W. Shupp, MD Burn care physicians must walk a fine line between providing individualized care and applying population-based quality metrics. AMA J Ethics. 2018;20(6):567-574. doi: 10.1001/journalofethics.2018.20.6.pfor1-1806.
Health Law Mar 2009 Difficult Patient-Physician Relationships and the Risk of Medical Malpractice Litigation Kristin E. Schleiter, JD Virtual Mentor. 2009;11(3):242-246. doi: 10.1001/virtualmentor.2009.11.3.hlaw1-0903.
Policy Forum Oct 2004 The Universal Protocol Dennis S. O'Leary, MD Virtual Mentor. 2004;6(10):456-458. doi: 10.1001/virtualmentor.2004.6.10.pfor1-0410.
Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410.
Medical Education Oct 2004 Acknowledging the Limits of Individual Competence Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):446-448. doi: 10.1001/virtualmentor.2004.6.10.medu1-0410.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Viewpoint Feb 2016 Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases Ajay Singhvi, MD, Alexandra N. Welch, Josh Levitsky, MD, Deepti Singhvi, MD, and Elisa J. Gordon, PhD, MPH Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters. AMA J Ethics. 2016;18(2):163-173. doi: 10.1001/journalofethics.2017.18.2.sect1-1602.
Policy Forum Feb 2016 Regulations’ Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? Joel T. Adler, MD, MPH and David A. Axelrod, MD, MBA Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit. AMA J Ethics. 2016;18(2):133-142. doi: 10.1001/journalofethics.2017.18.2.pfor1-1602.